Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up - European Society for Medical Oncology (ESMO)
Kidney cancer accounts for 5% and 3% of all adult malignancies in men and women, respectively, thus representing the 7th most common cancer in men and the 10th most common cancer in women. These updated ESMO guidelines cover incidence and epidemiology, diagnosis and pathology/molecular biology, staging and risk assessment, management of local and metastatic disease, response evaluation and follow-up, long-term implications and survivorship.
Read full Guideline